During the largest annual cancer research meeting, AACR
(American Association for Cancer Research), in Atlanta, Georgia in
April, 2019, Legal Drugs Podcast host, Angela Stoyanovitch, met up
with LinkedIn friend, Dr. Vijaya Kumar Pidugu, Ph.D. or "VJ." VJ
walks us through his poster presentation in the exhibit hall.
As this is an audible recording and you cannot see all the
charts and diagrams on the printed poster, you will have to use
your imagination to follow along in this week's interview.
Angela interrupts the recording to break things down for the
listener who may not have a basic science, research or specific
cancer research background to the best of her understanding (in
order to make it relatable.) She believes there is still room
for every listener to gain insight into cancer research and get
into the brain of the cancer research scientist even through the
heavy technical discussion. At the end of the recording, VJ
breaks down his goals and hope to impact society and those affect
by human oral cancer thanks to the characterizations he will
publish on this work. His work encompasses many details about
how certain components (oncogenes of cancer genes) in the body (our
biology) are either promoting or fighting cancer. Through his
studies, VJ looks at the mechanism of how these components (or
proteins, specifically) activate certain genes, for example. By
looking at these gene activations, decisions can be made to
determine the best possible drug for an individual patient.
If every cancer patient is screened for histochemistry (or
tissue chemistry constituents) than decisions can be made about
which patient's proteins may be susceptible to certain legal drugs.
As a result of this work, perhaps new drugs will be discovered to
target these proteins or activating triggers, in other words, and
help fight oral cancer. For more information, email VJ
. Thanks to VJ for exposing our
listeners to the details of this specific cancer research project
and giving all of us a glimpse into cancer legal drug development
as it relates to personalized medicine in the near
This episode edited and produced by Margaret
Beveridge, aka Maggie Bev.